On 10 November 2016
Rubra Medicaments will hold a meeting of the Board of Directors of the Company on 10 November 2016, to discuss and approve the unaudited Financial Result for the quarter and half year ended on 30 September 2016.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content